| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8519351 | Contemporary Clinical Trials Communications | 2018 | 9 Pages |
Abstract
A single intravesical instillation of Mitomycin before radical nephro-ureterectomy or partial ureterectomy may reduce the risk of a bladder recurrence in patients treated for UUT urothelial carcinoma and will circumvent the disadvantages of current therapy.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
T. van Doeveren, P.J. van Leeuwen, K.K.H. Aben, M. van der Aa, M. Barendrecht, E.R. Boevé, E.B. Cornel, A.G. van der Heijden, K. Hendricksen, W. Hirdes, A. Kooistra, B. Kroon, A.M. Leliveld, R.P. Meijer, H. van Melick, B. Merks, T.M. de Reijke,